{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T09:50:33Z","timestamp":1772013033700,"version":"3.50.1"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","drugandalcoholdependence.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.drugalcdep.2017.05.023","type":"journal-article","created":{"date-parts":[[2017,6,23]],"date-time":"2017-06-23T08:45:16Z","timestamp":1498207516000},"page":"348-354","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"special_numbering":"C","title":["Impact of New York prescription drug monitoring program, I-STOP, on statewide overdose morbidity"],"prefix":"10.1016","volume":"178","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2053-3931","authenticated-orcid":false,"given":"Richard","family":"Brown","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moira R.","family":"Riley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lydia","family":"Ulrich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ellen Percy","family":"Kraly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Jenkins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole L.","family":"Krupa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Gadomski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2017.05.023_bib0005","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1377\/hlthaff.2015.1673","article-title":"Prescription drug monitoring programs are associated with sustained reductions in opioid prescribing by physicians","volume":"35","author":"Bao","year":"2016","journal-title":"Health Aff."},{"key":"10.1016\/j.drugalcdep.2017.05.023_bib0010","doi-asserted-by":"crossref","first-page":"15078","DOI":"10.1073\/pnas.1518393112","article-title":"Rising morbidity and mortality in midlife among white non-hispanic Americans in the 21st century","volume":"112","author":"Case","year":"2015","journal-title":"PNAS"},{"key":"10.1016\/j.drugalcdep.2017.05.023_bib0015","series-title":"Increase in Fatal Poisonings Involving Opioid Analgesics in the United States, 1999\u20132006","author":"Centers For Disease Control and Prevention","year":"2009"},{"key":"10.1016\/j.drugalcdep.2017.05.023_bib0020","series-title":"Multiple Cause of Death Files from the National Vital Statistics System, 2002\u20132013","author":"Centers For Disease Control and Prevention","year":"2016"},{"key":"10.1016\/j.drugalcdep.2017.05.023_bib0025","series-title":"Calculating Total Daily Dosage of Opioids for Safer Dosage","author":"Centers For Disease Control and Prevention","year":"2016"},{"key":"10.1016\/j.drugalcdep.2017.05.023_bib0030","series-title":"Prescription Drug Monitoring Programs (PDMPs)","author":"Centers For Disease Control and Prevention","year":"2016"},{"key":"10.1016\/j.drugalcdep.2017.05.023_bib0035","series-title":"Drug Overdose Deaths in the United States Continue to Increase in 2015","author":"Centers For Disease Control and Prevention","year":"2016"},{"key":"10.1016\/j.drugalcdep.2017.05.023_bib0040","series-title":"CDC Guideline for Prescribing Opioids for Chronic Pain","author":"Centers For Disease Control and Prevention","year":"2016"},{"key":"10.1016\/j.drugalcdep.2017.05.023_bib0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugalcdep.2016.04.033","article-title":"Impact of prescription drug monitoring programs and pill mill laws on high-risk opioid prescribers: a comparative interrupted time series analysis","volume":"165","author":"Chang","year":"2016","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2017.05.023_bib0050","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1056\/NEJMra1508490","article-title":"Relationship between nonmedical prescription-opioid use and heroin use","volume":"374","author":"Compton","year":"2016","journal-title":"N. Engl J. Med."},{"key":"10.1016\/j.drugalcdep.2017.05.023_bib0055","doi-asserted-by":"crossref","first-page":"e178","DOI":"10.2196\/jmir.2810","article-title":"Crowdsourcing black market prices for prescription opioids","volume":"15","author":"Dasgupta","year":"2013","journal-title":"J. Med. Internet Res."},{"key":"10.1016\/j.drugalcdep.2017.05.023_bib0060","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1377\/hlthaff.2016.0448","article-title":"Mandatory provider review and pain clinic laws reduce the amounts of opioids prescribed and overdose death rates","volume":"35","author":"Dowell","year":"2016","journal-title":"Health Aff."},{"key":"10.1016\/j.drugalcdep.2017.05.023_bib0065","series-title":"ARCOS. Automation of Reports and Consolidated Orders System","author":"Drug Enforcement Administration","year":"2017"},{"key":"10.1016\/j.drugalcdep.2017.05.023_bib0070","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1002\/pds.3404","article-title":"High correlations between levels of consumption and mortality related to strong prescription opioid analgesics in British Columbia and Ontario, 2005\u20132009","volume":"22","author":"Fischer","year":"2013","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"10.1016\/j.drugalcdep.2017.05.023_bib0075","first-page":"1","volume":"190","author":"Hedegaard","year":"2015"},{"key":"10.1016\/j.drugalcdep.2017.05.023_bib0080","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.mayocp.2015.04.012","article-title":"Incidence and risk factors for progression from short-term to episodic or long-term opioid prescribing: a population-based study","volume":"90","author":"Hooten","year":"2015","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.drugalcdep.2017.05.023_bib0085","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.drugalcdep.2013.01.007","article-title":"Heroin use and heroin use risk behaviors among nonmedical users of prescription opioid pain relievers\u2013United States, 2002\u20132004 and 2008\u20132010","volume":"132","author":"Jones","year":"2013","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2017.05.023_bib0090","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.annemergmed.2016.08.445","article-title":"Novel synthetic opioids: an opioid epidemic within an opioid epidemic","volume":"69","author":"Lucy","year":"2017","journal-title":"Ann. Emerg. Med."},{"key":"10.1016\/j.drugalcdep.2017.05.023_bib0095","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.drugalcdep.2015.12.025","article-title":"Effect of a pill mill law on opioid prescribing and utilization: the case of Texas","volume":"159","author":"Lyapustina","year":"2016","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2017.05.023_bib0100","series-title":"Comments and Recommendations for the Internet System for Tracking Over-Prescribing Act (I-STOP) Proposed Regulations, Part 80 of Title 10 NYCRR","author":"New York City Bar","year":"2013"},{"key":"10.1016\/j.drugalcdep.2017.05.023_bib0105","unstructured":"New York State \u2013 County Opioid Quarterly Report For Counties Outside of New York City. New York State Department of Health, 2016 Available from: https:\/\/www.health.ny.gov\/diseases\/aids\/general\/opioid_overdose_prevention\/docs\/ros_2015_2016.pdf."},{"key":"10.1016\/j.drugalcdep.2017.05.023_bib0110","unstructured":"New York State Department of Health, 2016 Available from: https:\/\/www.health.ny.gov\/diseases\/aids\/general\/opioid_overdose_prevention\/docs\/ros_2015_2016.pdf."},{"key":"10.1016\/j.drugalcdep.2017.05.023_bib0115","series-title":"Report to the Governor and NYS Legislature. New York State Department of Health","author":"New York State Opioid Poisoning, Overdose and Prevention","year":"2015"},{"key":"10.1016\/j.drugalcdep.2017.05.023_bib0120","series-title":"Health Facility General Information","author":"New York State","year":"2017"},{"key":"10.1016\/j.drugalcdep.2017.05.023_bib0125","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1001\/jama.2016.1910","article-title":"The CDC guideline on opioid prescribing: rising to the challenge","volume":"315","author":"Olsen","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.drugalcdep.2017.05.023_bib0130","first-page":"491","article-title":"Decrease in rate of opioid analgesic overdose deaths\u2014Staten Island, New York City, 2011\u20132013","volume":"64","author":"Paone","year":"2015","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.drugalcdep.2017.05.023_bib0135","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1377\/hlthaff.2015.1496","article-title":"Implementation of prescription drug monitoring programs associated with reductions in opioid-related death rates","volume":"35","author":"Patrick","year":"2016","journal-title":"Health Aff."},{"key":"10.1016\/j.drugalcdep.2017.05.023_bib0140","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1080\/02791072.2012.704591","article-title":"Hooked on prescription-type opiates prior to using heroin: results from a survey of syringe exchange clients","volume":"44","author":"Peavy","year":"2012","journal-title":"J. Psychoactive Drugs"},{"key":"10.1016\/j.drugalcdep.2017.05.023_bib0145","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1370\/afm.1735","article-title":"Geographic and specialty distribution of US physicians trained to treat opioid use disorder","volume":"13","author":"Rosenblatt","year":"2015","journal-title":"Ann. Fam. Med."},{"key":"10.1016\/j.drugalcdep.2017.05.023_bib0150","first-page":"849","article-title":"Increases in heroin overdose deaths\u201428 States: 2010\u20132012","volume":"63","author":"Rudd","year":"2014","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.drugalcdep.2017.05.023_bib0155","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1111\/ajt.13776","article-title":"Increases in drug and opioid overdose deaths\u2014United States, 2000\u20132014","volume":"16","author":"Rudd","year":"2016","journal-title":"A. J. Transplant."},{"key":"10.1016\/j.drugalcdep.2017.05.023_bib0160","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1377\/hlthaff.2014.1085","article-title":"Most primary care physicians are aware of prescription drug monitoring programs, but many find the data difficult to access","volume":"34","author":"Rutkow","year":"2015","journal-title":"Health Aff."},{"key":"10.1016\/j.drugalcdep.2017.05.023_bib0165","series-title":"Prescription Drug Bill I-STOP Passes Both Chambers. Times Union","author":"Seller","year":"2012"},{"key":"10.1016\/j.drugalcdep.2017.05.023_bib0170","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1007\/s12024-015-9699-z","article-title":"Prescription opioid related deaths in New York City: a 2year retrospective analysis prior to the introduction of the New York State I-STOP law","volume":"11","author":"Sgarlato","year":"2015","journal-title":"Forensic Sci. Med. Pathol."},{"key":"10.1016\/j.drugalcdep.2017.05.023_bib0175","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1177\/003335491513000411","article-title":"Drug overdose deaths. Let's get specific","volume":"130","author":"Slavova","year":"2015","journal-title":"Public Health Rep."},{"key":"10.1016\/j.drugalcdep.2017.05.023_bib0180","doi-asserted-by":"crossref","first-page":"109","DOI":"10.5055\/jom.2011.0053","article-title":"Primary care physician opinion survey on FDA opioid risk evaluation and mitigation strategies","volume":"7","author":"Slevin","year":"2010","journal-title":"Opioid Manage."},{"key":"10.1016\/j.drugalcdep.2017.05.023_bib0185","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1111\/pme.12700","article-title":"How, why, and for whom do emergency medicine providers use prescription drug monitoring programs?","volume":"16","author":"Smith","year":"2015","journal-title":"Pain Med."},{"key":"10.1016\/j.drugalcdep.2017.05.023_bib0190","unstructured":"US Department of Justice 2014 Available from: https:\/\/www.deadiversion.usdoj.gov\/mtgs\/drug_chemical\/2014\/barrett.pdf."},{"key":"10.1016\/j.drugalcdep.2017.05.023_bib0195","doi-asserted-by":"crossref","first-page":"e54496","DOI":"10.1371\/journal.pone.0054496","article-title":"Intertwined epidemics: national demographic trends in hospitalizations for heroin-and opioid-related overdoses, 1993\u20132009","volume":"8","author":"Unick","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.drugalcdep.2017.05.023_bib0200","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1056\/NEJMp1402780","article-title":"Medication-assisted therapies\u2014tackling the opioid-overdose epidemic","volume":"370","author":"Volkow","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.drugalcdep.2017.05.023_bib0205","doi-asserted-by":"crossref","first-page":"231","DOI":"10.23907\/2013.029","article-title":"State variation in certifying manner of death and drugs involved in drug intoxication deaths","volume":"3","author":"Warner","year":"2013","journal-title":"Acad. Foren. Path."}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871617302971?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871617302971?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,26]],"date-time":"2019-09-26T15:23:42Z","timestamp":1569511422000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871617302971"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":41,"alternative-id":["S0376871617302971"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2017.05.023","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of New York prescription drug monitoring program, I-STOP, on statewide overdose morbidity","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2017.05.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}